Tag: DCGI
-
New year begins on a happy note as India’s expert panel clears Oxford vaccine, Covishield
Oxford vaccine: India has moved one step closer to getting its Covid-19 vaccine rollout approved as the expert panel has cleared use of Covishield, the Oxford-AstraZeneca vaccine being developed by Pune based Serum Institute of India. On Friday, the expert panel at DCGI (Drugs Controller General of India) gave its recommendation for EUA (emergency use ... -
Covid-19 vaccine: SII & Bharat Biotech emergency vaccine approval put on hold, DCGI cites lack of data
SII & Bharat Biotech: India’s hopes of getting Covid-19 vaccines in a matter of days flickered away – India might have to wait just a bit longer to get a country-made vaccine rolled out for the coronavirus. Drug Controller General of India (DCGI) has put the Covid-19 vaccines Covishield and Covaxin on hold for emergency ... -
First logistics blueprints released by expert committee regarding Covid-19 vaccination drive in India
First logistics blueprints: After Pfizer and Serum Institute of India approached India’s medical regulatory body DCGI seeking approval for their vaccine against Covid-19, Hyderabad-based Bharat Biotech too approached the body on Monday for approval of India’s first indigenous Covid-19 vaccine, Covaxin. Citing the progress country is making in manufacturing and procuring Covid-19 vaccine, high level ... -
Serum Institute of India applies for emergency use approval of Covishield, becomes first Indian firm to do so
Serum Institute of India: On Sunday, Serum Institute of India became the first indigenous pharma firm to apply for emergency use of Covishield, the Covid-19 vaccine. SII applied to DCGI (Drugs Controller General of India), India’s drug regulator, seeking authorization for Oxford vaccine’s emergency use in India. This comes a day after DCGI approved emergency ... -
India to get first AYUSH-approved ayurvedic COVID-19 drug
India to get first AYUSH-approved ayurvedic COVID-19 drug: YUSH Ministry has approved the manufacture of an ayurvedic drug for treatment of COVID-19 disease Dalmia Healthcare is all set to launch a polyherbal combination of 15 herbs called Astha-15 for the treatment of COVID-19 disease. Its research centre, Dalmia Centre for Research and Development (DCRD), has ...